When was Tissuemed founded?

Tissuemed was founded in 1985 and raised its 1st funding round 14 years after it was founded.

Where is Tissuemed located?

Tissuemed is headquartered in Leeds, United Kingdom.

How many employees does Tissuemed have?

As of May 31, 2026, the latest employee count at Tissuemed is 44811.

Is Tissuemed a funded company?

Tissuemed is a funded company, having raised a total of $12.7M across 6 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on May 01, 1999.

When was the latest funding round of Tissuemed?

Tissuemed's latest funding was a $***** Grant (prize money) round on Nov 30, 2015, with participation from 1 investor. Its primary sector is Surgical Instruments. In United Kingdom, the Surgical Instruments sector has seen $426M in funding in 2026 to date.

Where does Tissuemed rank among its competitors?

Tissuemed ranks 12th amongst 71 active competitors, of which 18 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was BRIJ Medical, which secured $5M in Oct, 2026.

Who are the top competitors of Tissuemed?

Tissuemed's top competitors include TYBR Health, Vivostat and BRIJ Medical. Among them, BRIJ Medical secured the most recent funding round in October, 2026.

Tissuemed - 2026 Company Profile, Team, Funding & Competitors

Company Details

Tissuemed develops and markets synthetic, self-adhesive, bioadhesive films to prevent air, blood, CSF and other fluid leaks encountered in surgery. All products incorporate a patented polymer on one side that bonds to tissue surfaces. The other surface is non-adhesive, providing favourable structural characteristics, ease of handling and potentially preventing post-surgical adhesions. TissuePatch films are ultimately resorbable and, reassuringly, based on polymers commonly used in other implants. Flagship product TissuePatchDural is used for prevention of CSF leaks in Neuro and Spinal surgery when the Dura Mater has been breached. Tissuemed has been granted regulatory approval of its TissuePatch range of ultra-thin surgical sealant films by Chinese FDA.

Website: tissuemed.com
Social
Email ID: *****@tissuemed.com

Key Metrics

Founded Year

1985

Location

Leeds, United Kingdom

Stage

Acqui-Hired

Total Funding

$12.7M in 6 rounds

Latest Funding Round

Grant (prize money), Nov 30, 2015, $*****

Investors

Saints Capital & 6 more

Ranked

12^th among 71 active competitors

Employee Count

44,811 as on May 31, 2026

Similar Companies

TYBR Health & 80 more

View Tissuemed's full profile

Tissuemed is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Tissuemed Limited CIN: 1902503 , Germany, Active		-	19 (As on Mar 31, 2022)

Tissuemed has raised a total funding of $12.7M over 6 rounds. Its first funding round was on May 01, 1999. Its latest funding round was a Grant (prize money) round on Nov 30, 2015 for $*****. 1 investor participated in its latest round. Tissuemed has 7 institutional investors.

Here is the list of recent funding rounds of Tissuemed:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 30, 2015	8397145	Grant (prize money)	8020264	1630223	9763631	4843940
Jul 15, 2015	9004055	Grant (prize money)	8934423	5515180	8058670	Gov
Jun 01, 2015	7027153	Grant (prize money)	7819613	1536604	7811932	Europa

Access funding benchmarks and valuations. Sign up today!

View details of Tissuemed's funding rounds and investors

Here are the details of Tissuemed's key team members:

David Mandley: CEO of Tissuemed. They serve on the board of 1 company.

Tissuemed's Board of Directors

Tissuemed's board has 5 active members. Michael Henderson is part of team and Ian Thompson, Jeremy David Sampson, Paul Lancelot Banner and Peter Maver are independent board members.

Here is the list of Tissuemed's board of directors:

Name	Type	Representing	Status	Duration
Michael Henderson	Team	-	Current	33y 0m
Ian Thompson	Independent board member	-	Current	8y 7m
quizvuq	Independent board member	-	Current	6y 8m
gguvvyb	Independent board member	-	Current	4y 5m
edqxwwh	Independent board member	-	Current	7y 6m
nzrzywa	Independent board member	-	Past	4y 8m
qgopycu	Independent board member	-	Past	7y 6m
kxoomrk	Independent board member	-	Past	4y 5m
irgfgbj	Independent board member	-	Past	6y 9m
lnmkbcm	Independent board member	-	Past	7y 4m
jx{ucnz	Independent board member	-	Past	6y 8m
jxmgvuh	Independent board member	-	Past	9y 6m
xmxlcbh	Independent board member	-	Past	7y 9m
vbjwyyu	Independent board member	-	Past	5y 1m
bjqzxrw	Independent board member	-	Past	3y 5m
xzvthxg	Independent board member	-	Past	5y 8m
djdhmmg	Independent board member	-	Past	2y 9m
ywdayft	Independent board member	-	Past	2y 6m
tf{veil	Independent board member	-	Past	5y 7m
hdaud{{	Independent board member	-	Past	6y 9m
bjgrdbu	Independent board member	-	Past	8y 9m
xkokloo	Independent board member	-	Past	9y 5m
rhpxdex	Independent board member	-	Past	5y 2m
aogxriq	Independent board member	-	Past	4y 4m
exagtuf	Independent board member	-	Past	8y 3m
qcsnumg	Independent board member	-	Past	6y 5m
zflhsof	Independent board member	-	Past	4y 5m
ouhpngr	Independent board member	-	Past	4y 6m

View details of Tissuemed's Founder profiles and Board Members

Tissuemed's employee count trend

Tissuemed has 44,811 employees as of May 26. Here is Tissuemed's employee count trend over the years:

Uncover Tissuemed's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Tissuemed include TYBR Health, Vivostat and BRIJ Medical. Here is the list of Top 10 competitors of Tissuemed, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	TYBR Health 2020, Houston (United States), Series A	Provider of regenrative medicine for post surgical scarring	$38.4M	Vensana Capital, Y Combinator & 4 others	58/100
2nd	Vivostat 2001, Alleroed (Denmark), Acquired	Provider of on-site preparation of fibrin sealants	$12.9M	Sunstone, Omega Funds & 5 others	53/100
3rd	BRIJ Medical 2016, Marietta (United States), Seed	Provider of a medical devices for post-surgical and trauma incision care	$11.8M	-	52/100
4th	Cousin Surgery 1848, Wervicq Sud (France), Funding Raised	Manufacturer of implantable textile medical devices for spine and visceral surgery. It develops innovative implants to advance visceral and spine surgery, focusing on preserving mobility and reducing post-operative pain. The company collaborates closely with surgeons and utilizes unique expertise in implantable textiles. Its product portfolio includes solutions for various surgical specialties, such as orthopedics, uro-gynecology, and bariatric surgery, along with adhesion prevention and hemostasis products. The company also offers subcontracting services and technological support.	-	Turenne Groupe, Nord Capital Partenaires	48/100
5th	Adhezion Biomedical 2001, Wyomissing (United States), Acquired	Developer of cyanoacrylate based surgical, wound management, and infection prevention products	$13.3M	Originate Ventures, Liberty Venture Partners ... & 1 others	45/100
6th	SanaHeal 2021, Cambridge (United States), Funding Raised	Provider of bioadhesive tape for healthcare	-	Archerman Capital, E14 Fund & 4 others	43/100
7th	PolarSeal 2006, Saxmundham (United Kingdom), Unfunded	Manufacturer and supplier of adhesive tapes for hospital use	-	-	42/100
8th	Neomend 1999, Irvine (United States), Acquired	Provider of air leak sealant for thoracic surgery	$38.8M	Vivo Capital, Novo Holdings & 4 others	41/100
9th	Sylke 2023, La Jolla (United States), Series B	Provider of medical device company	$15.5M	Vaark	40/100
10th	Mussel Polymers 2019, Bethlehem (United States), Series A	Manufacturer of adhesive solutions for multiple applications	$7.33M	Ben Franklin Technology Partners	39/100
12th	Tissuemed 1985, Leeds (United Kingdom), Acqui-Hired	Bioadhesive films to prevent body fluid and air leakage during surgery	$12.7M	Saints Capital, Shackleton Ventures & 5 others	39/100